Monogram Orthopaedics Inc. Common Stock (MGRM) — Strategic Asset Allocation Index
Monogram Orthopaedics Inc. Common Stock (MGRM) has a Strategic Asset Allocation Index of 12.7% as of June 2023. Strategic assets (PP&E of $1.55 Million plus long-term investments of $-) total $1.55 Million, measured against net assets of $12.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Monogram Orthopaedics Inc. Common Stock (MGRM) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Monogram Orthopaedics Inc. Common Stock Strategic Asset Allocation Index (2020–2022)
This chart shows how Monogram Orthopaedics Inc. Common Stock's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 12.7%, representing strategic assets of $1.55 Million against net assets of $12.20 Million USD. For live market cap and overall valuation, see market value of Monogram Orthopaedics Inc. Common Stock.
Annual Strategic Asset Allocation Index for Monogram Orthopaedics Inc. Common Stock (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Monogram Orthopaedics Inc. Common Stock from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See MGRM book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 40.4% | $1.67 Million | $1.67 Million | $- | $4.15 Million | ▲ +5.2 pp |
| 2021 | 35.2% | $1.23 Million | $1.23 Million | $- | $3.50 Million | ▲ +4.6 pp |
| 2020 | 30.6% | $1.53 Million | $1.53 Million | $- | $4.99 Million | — |